Friday, September 19, 2014 9:45:35 AM
Nola Masterson joining the board of HEPI is "worthless" and should not be made know to the shareholders and investing community ?
By "help the stock" clearly you mean boost the stock price as does everyone else around here. If you value this company based on stock price, you are missing the boat completely and its clearly evidenced by all the shallow comments posted here.
Nothing happened when John Payne joined the board either eh ??? (if the news is so great, why didn't the stock go up ?? ROFLMAO ..... sounds like a question a child might ask a parent) Funny, HEPI landed a collaboration with Zoetis less than 6 months after he came on board. Coincidence ??? Doubt it. Folks here really think HEPI lands ZTS without Payne ???? C'mon ..... really ?
Don't think Nola Masterson is well known in the science community and has many contacts ??? And her knowledge and contacts WON'T help the stock (at some point in the future) ??? Has to help the stock immediately today ?? Pretty shortsighted don't ya think ??? Hey ... stock was up almost 10% yesterday .... not a peep about that ......
It is hilarious the value of ANYTHING associated with HEPI is solely based on the stock price or its reactions to some piece of news or filing. Is that how you people value a company ?? If it is ...... wow ..... and all that would happen is the stock would fall back in a few days ..... and we'd get the "head fake" BS comments.
And the headline should have read:
"Biotech Pioneer Nola Masterson joins Board of Health Enhancement Products".
When that comes across the news headline ...... those that know who Nola Masterson is would be very likely take a look. The headline that was written is worthless junk.
- HEPI's company name isn't even complete in the headline.
- Masterson not mentioned.
- Who gives a chit that some unnamed person is being added to the board before annual meeting. That is totally irrelevant.
- And no quote from Masterson .... easy opportunity for shareholders to hear why she joined the board of a company that most everyone here thinks is any number of negative adjectives. There are no other real opportunities to have a director quoted.
If PR company was consulted on this .... they should be fired.
Bottom line, COMPANIES ARE BUILT. THEY DO NOT JUST HAPPEN ONE DAY. CLEARLY SOMETHING IS BEING BUILT ..... THAT INCLUDES A BOARD OF DIRECTORS THAT HAS EXPERIENCE AT THE EXECUTIVE LEVELS OF COMPANIES IN THE TARGET MARKETS.
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM